Avlayah (tividenofusp alfa-eknm)

Approved for To treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II). 12.1 Mechanism of Action Hunter syndrome is an inherited X-linked recessive lysosomal storage disease caused by a deficiency of iduronate-2-sulfatase (IDS), a lysosomal enzyme, that degrades heparan… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA…

Loading full data from Know Your Drugs Institute…